17/06/2026
💜 More than 10 million people worldwide live with Inflammatory Bowel Disease (IBD), yet many still face delays in diagnosis, unequal access to care, and barriers to innovation.
In the latest edition of , IFCCA's Innovation and Patient Engagement Coordinator, Roberto Saldaña shares his perspective on the challenges facing the IBD community, the promise of advanced therapies, and why patient voices must be at the heart of research, policy, and healthcare decisions.
As a proud partner of the TRANSFORM Alliance, IFCCA is pleased to contribute to this important conversation on the future of healthcare innovation.
📖 Read the full interview:
This week, puts a spotlight on inflammatory bowel disease and the transformative therapies that could change everything for the millions living with it. Roberto Saldaña, from the International Federation of Crohn's and Ulcerative Colitis Associations (IFCCA), tells us mor...